The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 30, 2025 | Amit Sharma | Director | Tender(U) | 94K | — | — |
| May 30, 2025 | Bechon Christian | Director | Tender(U) | 142K | — | — |
| May 30, 2025 | Gray William Garrett | Chief Financial Officer | Tender(U) | 1.4M | — | — |
| May 30, 2025 | Herskowitz Neil | Director | Tender(U) | 147K | — | — |
| May 30, 2025 | Oliviero James F III | CEO, President and Director, Director | Tender(U) | 3.8M | — | — |
| May 30, 2025 | Rosenwald Lindsay A MD | Director | Tender(U) | 207K | — | — |
| May 30, 2025 | Salzman Barry M | Director | Tender(U) | 147K | — | — |
| May 30, 2025 | Weiss Michael S | Director | Tender(U) | 187K | — | — |
| May 30, 2025 | Fortress Biotech, Inc. | 10% Owner | Disposed to issuer(D) | 6.1M | $4.10 | $25.1M |
| May 30, 2025 | Fortress Biotech, Inc. | 10% Owner | Disposed to issuer(D) | 700K | — | $0 |
| May 29, 2025 | Rosenwald Lindsay A MD | Director | Grant(A) | 50K | $1.29 | $65K |
| May 29, 2025 | Weiss Michael S | Director | Grant(A) | 50K | $1.29 | $65K |
| May 29, 2025 | Fortress Biotech, Inc. | 10% Owner | Sell(S) | 100K | $1.29 | $129K |
| May 28, 2025 | Amit Sharma | Director | Grant(A) | 12K | — | $0 |
| May 28, 2025 | Bechon Christian | Director | Grant(A) | 12K | — | $0 |
| May 28, 2025 | Herskowitz Neil | Director | Grant(A) | 12K | — | $0 |
| May 28, 2025 | Rosenwald Lindsay A MD | Director | Grant(A) | 12K | — | $0 |
| May 28, 2025 | Salzman Barry M | Director | Grant(A) | 12K | — | $0 |
| May 28, 2025 | Weiss Michael S | Director | Grant(A) | 12K | — | $0 |
| Apr 2, 2025 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 15K | $4.04 | $61K |
| Apr 1, 2025 | Gray William Garrett | Chief Financial Officer | Sell(S) | 12K | $4.05 | $50K |
| Feb 26, 2025 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 19K | — | $0 |
| Feb 10, 2025 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 10K | $3.15 | $33K |
| Feb 7, 2025 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 9K | $3.41 | $31K |
| Feb 6, 2025 | Gray William Garrett | Chief Financial Officer | Sell(S) | 74K | $3.67 | $272K |
| Jan 30, 2025 | Oliviero James F III | CEO, President and Director, Director | Grant(A) | 1.5M | — | $0 |
| Jan 30, 2025 | Gray William Garrett | Chief Financial Officer | Grant(A) | 500K | — | $0 |
| Jan 1, 2025 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 2.4M | — | $0 |
| Dec 31, 2024 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 81K | — | $0 |
| Dec 20, 2024 | Oliviero James F III | CEO, President and Director, Director | Gift(G) | 900K | — | $0 |
| Dec 19, 2024 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 220K | $3.38 | $744K |
| Dec 18, 2024 | Gray William Garrett | Chief Financial Officer | Sell(S) | 268K | $4.01 | $1.1M |
| Dec 18, 2024 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 602K | $3.87 | $2.3M |
| Dec 13, 2024 | Herskowitz Neil | Director | Grant(A) | 18K | — | $0 |
| Dec 13, 2024 | Bechon Christian | Director | Grant(A) | 15K | — | $0 |
| Dec 13, 2024 | Gray William Garrett | Chief Financial Officer | Grant(A) | 629K | — | $0 |
| Dec 13, 2024 | Oliviero James F III | CEO, President and Director, Director | Grant(A) | 2.1M | — | $0 |
| Dec 13, 2024 | Rosenwald Lindsay A MD | Director | Grant(A) | 13K | — | $0 |
| Dec 13, 2024 | Salzman Barry M | Director | Grant(A) | 18K | — | $0 |
| Dec 13, 2024 | Weiss Michael S | Director | Grant(A) | 13K | — | $0 |
| Sep 27, 2024 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 146K | — | $0 |
| Jun 26, 2024 | Gray William Garrett | Chief Financial Officer | Sell(S) | 13K | $2.06 | $27K |
| Jun 26, 2024 | Oliviero James F III | CEO, President and Director, Director | Gift(G) | 38K | — | $0 |
| Jun 26, 2024 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 25K | $2.05 | $50K |
| May 24, 2024 | Oliviero James F III | CEO, President and Director, Director | Grant(A) | 1.7M | — | $0 |
| May 24, 2024 | Gray William Garrett | Chief Financial Officer | Grant(A) | 540K | — | $0 |
| May 14, 2024 | Bechon Christian | Director | Grant(A) | 50K | — | $0 |
| May 14, 2024 | Bechon Christian | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Herskowitz Neil | Director | Grant(A) | 50K | — | $0 |
| May 14, 2024 | Herskowitz Neil | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Rosenwald Lindsay A MD | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Rosenwald Lindsay A MD | Director | Grant(A) | 50K | — | $0 |
| May 14, 2024 | Salzman Barry M | Director | Grant(A) | 50K | — | $0 |
| May 14, 2024 | Salzman Barry M | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Amit Sharma | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Weiss Michael S | Director | Grant(A) | 32K | — | $0 |
| May 14, 2024 | Weiss Michael S | Director | Grant(A) | 50K | — | $0 |
| Mar 20, 2024 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 194K | — | $0 |
| Feb 28, 2024 | Gray William Garrett | Chief Financial Officer | Sell(S) | 2K | $2.07 | $4K |
| Feb 28, 2024 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 6K | $2.06 | $12K |
| Feb 28, 2024 | Oliviero James F III | CEO, President and Director, Director | Gift(G) | 9K | — | $0 |
| Feb 1, 2024 | Oliviero James F III | CEO, President and Director, Director | Gift(G) | 13K | — | $0 |
| Feb 1, 2024 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 12K | $2.01 | $24K |
| Feb 1, 2024 | Gray William Garrett | Chief Financial Officer | Sell(S) | 4K | $1.95 | $8K |
| Dec 29, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 158K | — | $0 |
| Sep 25, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 81K | — | $0 |
| Jun 30, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 81K | — | $0 |
| Jun 13, 2023 | Bechon Christian | Director | Grant(A) | 17K | — | $0 |
| Jun 13, 2023 | Boilen Scott | Director | Grant(A) | 17K | — | $0 |
| Jun 13, 2023 | Herskowitz Neil | Director | Grant(A) | 17K | — | $0 |
| Jun 13, 2023 | Rosenwald Lindsay A MD | Director | Grant(A) | 17K | — | $0 |
| Jun 13, 2023 | Salzman Barry M | Director | Grant(A) | 17K | — | $0 |
| Jun 13, 2023 | Weiss Michael S | Director | Grant(A) | 17K | — | $0 |
| Apr 4, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 43K | — | $0 |
| Mar 31, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 36K | — | $0 |
| Mar 31, 2023 | Gray William Garrett | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Mar 31, 2023 | Oliviero James F III | CEO, President and Director, Director | Grant(A) | 250K | — | $0 |
| Mar 2, 2023 | Gray William Garrett | Chief Financial Officer | Sell(S) | 4K | $5.00 | $18K |
| Mar 2, 2023 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 5K | $5.00 | $27K |
| Feb 27, 2023 | Gray William Garrett | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Feb 27, 2023 | Gray William Garrett | Chief Financial Officer | Sell(S) | 2K | $4.66 | $9K |
| Feb 27, 2023 | Oliviero James F III | CEO, President and Director, Director | Grant(A) | 15K | — | $0 |
| Feb 27, 2023 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 6K | $4.65 | $26K |
| Feb 1, 2023 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 10K | $4.77 | $49K |
| Feb 1, 2023 | Gray William Garrett | Chief Financial Officer | Sell(S) | 3K | $4.79 | $15K |
| Jan 10, 2023 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 4K | $6.75 | $26K |
| Jan 10, 2023 | Gray William Garrett | Chief Financial Officer | Sell(S) | 2K | $6.75 | $13K |
| Jan 5, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 369K | — | $0 |
| Jun 23, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 15K | $1.11 | $17K |
| Jun 22, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 12K | $1.09 | $13K |
| Jun 21, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 21K | $1.09 | $23K |
| Jun 17, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 228K | $1.09 | $249K |
| Jun 16, 2022 | Weiss Michael S | Director | Grant(A) | 48K | — | $0 |
| Jun 16, 2022 | Salzman Barry M | Director | Grant(A) | 48K | — | $0 |
| Jun 16, 2022 | Rosenwald Lindsay A MD | Director | Grant(A) | 48K | — | $0 |
| Jun 16, 2022 | Herskowitz Neil | Director | Grant(A) | 48K | — | $0 |
| Jun 16, 2022 | Boilen Scott | Director | Grant(A) | 48K | — | $0 |
| Jun 16, 2022 | Bechon Christian | Director | Grant(A) | 48K | — | $0 |
| Apr 13, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 21K | $1.51 | $32K |
| Apr 5, 2022 | Oliviero James F III | CEO, President and Director, Director | Sell(S) | 14K | $1.77 | $25K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).